Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
COVID-19 환자의 하이드록시클로로퀸 및 토실리주맙 요법 - 관찰 연구
Research Article
[키워드] adjusted
association
Azithromycin
benefit
caution
Chain Reaction
cohort study
Combination
COVID-19
Critically ill
critically ill patients
death
demonstrated
discharge
dose
Electronic health record
Electronic health records
Exploratory analysis
Hospitalization
Hospitalized
hospitalized COVID-19 patients
hospitalized patient
hospitalized patients
Hydroxychloroquine
ICU
ICU Patients
IL-6
inhibitor
inhibitor of IL-6
Mortality
New
no significant difference
no significant differences
Observational cohort study
Patient
polymerase chain
polymerase chain reaction
positive
propensity modeling
randomized trials
receiving
reduced
retrospective
SARS-CoV-2
survival
Tocilizumab
tocilizumab therapy
Treatment
Trial registration
USA
with COVID-19
[DOI] 10.1371/journal.pone.0237693 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0237693 PMC 바로가기 [Article Type] Research Article